AzTrials
AzTrials

Care Coordination in OncologyEPOCKNCT03350776

Practices and Organizations Related to Emerging Occupations of Care (EPOCK) Coordination in Oncology

An observational study of Care Coordination in Oncology, run by University Hospital, Bordeaux at 10 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Several stakeholders are implied in cancer care pathways and there is a need for coordinating their actions. New occupations of care coordination have thus emerged. However, the conditions of their efficiency have been too few reported and included discrepancies between reports. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Care Coordination in Oncology
What is being tested?
Care coordination
How many people
960 participants
Where
10 sitesFrance
Study dates
17 Apr 2018to 30 Oct 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Four samples : * Professionals of cancer care coordination * Cancer patients * Family caregivers of the selected patients * Professionals working with professionals of care coordination

Who may be able to join

  • For health institutions: public or private institutions in which nurses contributing to care coordination. Each institution will be associated with one type of coordination occupation, even if other healthcare workers contribute to care coordination in the same institution.
  • For professionals of care coordination: nurses contributing to care coordination in oncology (IDEC , IDE TAS, IPO, IDE AMA, IDE-CO, IDE HAD-CAD or IDE ETP)
  • For professionals working with professionals of care coordination:
  • Medical and non-medical healthcare professionals (oncologist, surgeon, nurses…), administrative professionals (secretary…), professionals of supportive care (psychologists, social workers…) and volunteers in patient organizations.
  • Private practitioners: general practitioner, private nurses, pharmacist
  • For the patients : adults under supervision of the selected professionals of care coordination for at least four weeks and able to express themselves
  • For the caregivers: family caregivers of the selected patients.

Who cannot join

  • For health institutions: private healthcare networks, territorial support platforms, home-based care providers, healthcare houses
  • For professionals of care coordination: coordinating medical doctors of care networks, coordinating medical doctors of hospital care at home, practitioners of regional cancer networks.
  • For the patients: <18 years old

Trial locations and contacts

10 sites in 1 country.

10 sites in 1 country

France10 sites
  • Institut Sainte Catherine

    Avignon

  • CHU de Bordeaux

    Bordeaux

  • Clinique Tiivoli Ducos

    Bordeaux

  • CH Sud Gironde

    Langon

  • CH de Libourne

    Libourne

  • Institut Curie

    Paris

  • Institut de Cancérologie de la Loire

    Saint-Priest

  • HAD Bagatelle

    Talence

  • CHU de Toulouse

    Toulouse

  • Institut Claudius Regaud

    Toulouse

Other trials in France

About this study

Official title: Pilot Observational and Analytic Study of Practices and Organizations Related to Emerging Occupations of Care Coordination in Oncology: Modeling the Concept of Care Coordination in Oncology (EPOCK)

Several stakeholders are implied in cancer care pathways and there is a need for coordinating their actions. New occupations of care coordination have thus emerged. However, the conditions of their efficiency have been too few reported and included discrepancies between reports. In this context, the main objective is to propose a modeling of care coordination and associated emerging occupations (nurse-based) by comparing theoretical expected outcomes to professionals, patients and caregivers representations.

Read the detailed description

Several stakeholders are implied in cancer care pathways and there is a need to coordinate their actions. New occupations of care coordination have thus emerged, such as nurse coordinator in France (IDEC: Infirmière de Coordination). However, the conditions of their efficiency are not well known. Moreover, several other complementary approaches and nurse occupations have to be identified because of their contribution to care coordination (IDE TAS, IPO, IDE AMA, IDE-CO, IDE HAD-CAD, IDE ETP)*. Finally, all together, these interventions of care coordination appeared as complex and asked for a theoretical model. Because of this high variability of the practices, without an underlying model, the impact of care coordination on patient quality of life, safety and efficiency of care is difficult to assess. In this context, the main objective is to propose a modeling of care coordination and associated emerging occupations by comparing theoretical expected outcomes to professionals, patients and caregivers representations.

The pilot observational study is based on three distinct stages: (1) the definition of care coordination in oncology using a literature review and a Delphi consensus study; (2) the description of practices, contexts, perceptions and attitudes related to care coordination occupations in oncology using a qualitative and a cross-sectional quantitative survey; (3) the comparison of the practices to the theoretical model to propose a modeling of care coordination occupations in oncology.

Being tested
Care coordination
Keywords
Neoplasm, Chronic disease, Complex cases, Care coordination, Oncologic nursing, Theoretical model
Medical subject headings
Neoplasms, Chronic Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Care coordinationBehavioural

    Care coordination and associated emerging occupations by comparing theoretical expected outcomes to professionals, patients and caregivers representations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Modeling of care coordination in Oncology in France

    Constitutive elements of modelling of care coordination in oncology in France (qualitative analysis)

    Measured: During the whole period (36 months: from Month 1 to Month 36)

Secondary outcomes (5)
  1. Care coordination profesionals quality of life

    Three scores : perceived organizational support, role conflict and commitment to the organization

    Measured: Quantitative cross sectional survey (from Month 10 to Month 29)

  2. Satisfaction with care coordination for profes professionals working with professionals of care coordination

    Score of satisfaction

    Measured: Quantitative cross sectional survey (from Month 10 to Month 29)

  3. Patients quality of life and satisfaction with care coordination

    Score of satisfaction and score of quality of life (measured with the European Organization for Research and Treatment (EORTC) quality of life questionnaire)

    Measured: Quantitative cross sectional survey (from Month 10 to Month 29)

  4. Caregivers burden with care coordination

    Score of burdean (Zarit Burden Interview) with care coordination

    Measured: Quantitative cross sectional survey (from Month 10 to Month 29)

  5. Caregivers satisfaction with care coordination

    Score of satisfaction with care coordination

    Measured: Quantitative cross sectional survey (from Month 10 to Month 29)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2017
  2. Study start17 Apr 2018
  3. Primary completion2 Oct 2019
  4. Study completion30 Oct 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
960 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03350776
Sponsor's protocol ID
CHUBX 2016/31
Acronym
EPOCK
Status last verified
Jun 2020
First submitted
9 Nov 2017
Last updated
19 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Colombani F, Calcagni N, Sibe M, Kret M, Fournier H, Ravaud A, Quintard B, Saillour-Glenisson F. Evidence-based modelling and taxonomy of hospital-based cancer care coordination nurses' roles and boundaries: an iterative multiphase convergent mixed study. BMJ Oncol. 2025 Nov 18;4(1):e000771. doi: 10.1136/bmjonc-2025-000771. eCollection 2025.

    PubMed 41323425
  • Colombani F, Sibe M, Kret M, Quintard B, Ravaud A, Saillour-Glenisson F. EPOCK study protocol: a mixed-methods research program evaluating cancer care coordination nursing occupations in France as a complex intervention. BMC Health Serv Res. 2019 Jul 12;19(1):483. doi: 10.1186/s12913-019-4307-7.

    PubMed 31299966

Questions about this trial

What is this clinical trial studying?

An observational study of Care Coordination in Oncology, run by University Hospital, Bordeaux at 10 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Modeling of care coordination in Oncology in France (time frame: During the whole period (36 months: from Month 1 to Month 36)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03350776, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in